Is This the Alzheimer’s Drug We’ve Been Waiting For?
By
Emily Woodruff
| July 26th, 2018
The long search for a drug to slow the decline of Alzheimer’s may have reached a turning point. Pharmaceutical companies Biogen and Eisai have…
Painkillers for Dementia Could Be Making Things Worse
By
Emily Woodruff
| July 24th, 2018
We know that as much as 50 percent of dementia patients experience regular pain. But does providing a common painkiller help or hurt patients?…
There’s Hope for an Alzheimer’s Drug. Here’s What You Need to Know
By
Emily Woodruff
| July 9th, 2018
After years of failure, including some pharmaceutical companies calling off Alzheimer’s research altogether, Biogen offers a glimmer of hope: New data from a Phase…
Aspirin for Alzheimer’s? Here’s What the Research Says
By
Emily Woodruff
| July 4th, 2018
Could an aspirin a day keep dementia away? A new study has added to the list of evidence that anti-inflammatories like aspirin might be…
Common Medications Linked to Dementia Risk
By
Emily Woodruff
| April 26th, 2018
Long-term use of certain drugs, some of them used to treat depression, has been linked to an increase in dementia risk in a study…
Dementia Patients Are Overly Medicated, Study Finds
By
Emily Woodruff
| April 20th, 2018
Jasja De Smedt Kotterman, whose mother died of Alzheimer’s in 2017, said she was always fearful that her mother was in pain toward the end…
The Path of an Alzheimer’s Drug, From Trials to Market
By
Emily Woodruff
| April 9th, 2018
Any Alzheimer’s drug under development has a complicated journey from formulation to clinical trials to potentially getting in the hands of patients. We spoke…
Follow us